Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pohanka

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Journal of Clinical Immunology|May 1, 1992
Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatmentG J Zlabinger, K M Stuhlmeier, R Eher, et al.
Clinical Nephrology|April 10, 2009
Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantationV Kliem, U Michel, M Burg, et al.
Transplantation Proceedings|December 31, 2003
One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST Observational StudyM Salvadori, A Rosati, A Bock, et al.
Transplantation Proceedings|April 6, 2005
Delayed graft function: risk factors, consequences and parameters affecting outcome-results from MOST, A Multinational Observational StudyY Lebranchu, J M Halimi, A Bock, et al.
Transplantation Proceedings|September 27, 2005
Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: analysis of the MOST databaseM Salvadori, A Bock, J Chapman, et al.
Transplantation Proceedings|June 8, 2006
Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational studyM Salvadori, A Rosati, E Bertoni, et al.
Transplantation Proceedings|December 20, 2007
Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapyJ R Chapman, H Valantine, J Albanell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 30, 2007
Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipientsT Heller, T van Gelder, K Budde, et al.
Transplantation|August 15, 1997
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study GroupA D Mayer, J Dmitrewski, J P Squifflet, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Clinical Immunology|May 1, 1992
Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatmentG J Zlabinger, K M Stuhlmeier, R Eher, et al.
Clinical Nephrology|April 10, 2009
Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantationV Kliem, U Michel, M Burg, et al.
Transplantation Proceedings|December 31, 2003
One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST Observational StudyM Salvadori, A Rosati, A Bock, et al.
Transplantation Proceedings|April 6, 2005
Delayed graft function: risk factors, consequences and parameters affecting outcome-results from MOST, A Multinational Observational StudyY Lebranchu, J M Halimi, A Bock, et al.
Transplantation Proceedings|September 27, 2005
Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: analysis of the MOST databaseM Salvadori, A Bock, J Chapman, et al.
Transplantation Proceedings|June 8, 2006
Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational studyM Salvadori, A Rosati, E Bertoni, et al.
Transplantation Proceedings|December 20, 2007
Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapyJ R Chapman, H Valantine, J Albanell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 30, 2007
Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipientsT Heller, T van Gelder, K Budde, et al.
Transplantation|August 15, 1997
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study GroupA D Mayer, J Dmitrewski, J P Squifflet, et al.
Pageof 8